James Kevin Hanna - Dec 8, 2023 Form 4 Insider Report for MEDICAL PROPERTIES TRUST INC (MPW)

Role: Senior VP, Controller & CAO
Signature: Matthew W. Stuenkel, by power of attorney
Stock symbol: MPW
Transactions as of: Dec 8, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/12/2023, 07:05 PM
Previous filing: Oct 12, 2023
Next filing: Jan 8, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MPW	Common stock, par value $0.001	Award	$0	+200K	+109.62%	$0.00	382K	Dec 8, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period following December 8, 2023 (the "Grant Date") as follows: (i) if the Company's share price increases to $7.00, 100% of the shares will be earned; (ii) if the Company's share price increases to $8.50, 200% of the shares will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 2).
F2	Earned shares will become vested in equal quarterly installments over two years following the date the shares are earned, subject to the grantee's continued employment through such date, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four-year performance period.

Content

The shares were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period following December 8, 2023 (the "Grant Date") as follows: (i) if the Company's share price increases to $7.00, 100% of the shares will be earned; (ii) if the Company's share price increases to $8.50, 200% of the shares will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 2).

Earned shares will become vested in equal quarterly installments over two years following the date the shares are earned, subject to the grantee's continued employment through such date, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four-year performance period.